FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CRESEMBA (isavuconazonium sulfate) from Astellas Pharma US, Inc., to support changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Mucormycosis

Drugs mentioned

• Cresemba (isavuconazole)

Snippet

SUPPL AP for CRESEMBA (ISAVUCONAZONIUM SULFATE)